24 (PB012): Runx1t1 is an epigenetic regulator essential for MYCN-driven neuroblastoma tumorigenesis
Murray D. Norris(Cancer Clinic), Michelle Haber(Cancer Clinic), Chelsea Mayoh(Cancer Institute of New South Wales), Andrew J. Gifford, Chaorong Xue(Fujian Medical University), Emanuele Valli, Glenn M. Marshall(The University of Sydney), Laura D. Gamble, Giorgio Milazzo(University of Bologna), Nisitha Jayatilleke, Giovanni Perini(University of Bologna), Jayne Murray, Jan Köster(Amsterdam UMC Location University of Amsterdam), Paride De Rosa, Jonathan A. Fletcher(Harvard University), Federico M. Giorgi(University of Bologna)
Cited by 0
Related Papers
Growth of Rhodococcus sp. strain BCP1 on gaseous n-alkanes: new metabolic insights and transcriptional analysis of two soluble di-iron monooxygenase genes
|Frontiers in Microbiology|2015|1.8k
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
|Oncogene|2001|700
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
|American Journal Of Pathology|2000|647